Cost-Effectiveness of Fidaxomicin for Clostridium difficile Treatment

被引:2
|
作者
Simon, Matthew S. [1 ,2 ]
机构
[1] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
[2] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA
关键词
VANCOMYCIN; INFECTION; CANCER;
D O I
10.1093/cid/cit772
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Fidaxomicin In Clostridium difficile Infection
    Duggan, Sean T.
    DRUGS, 2011, 71 (18) : 2445 - 2456
  • [32] Fidaxomicin: a new option for the treatment of Clostridium difficile infection
    Johnson, Alan P.
    Wilcox, Mark H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (12) : 2788 - 2792
  • [33] Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea
    Greig, James
    CLINICAL DRUG INVESTIGATION, 2013, 33 (01) : 93 - 94
  • [34] Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea
    James Greig
    Clinical Drug Investigation, 2013, 33 : 93 - 94
  • [35] Fidaxomicin for Clostridium difficile Infection
    Louie, Thomas J.
    Gorbach, Sherwood
    Sears, Pamela
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19): : 1875 - 1876
  • [36] Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged >= 60 years (EXTEND): analysis of cost-effectiveness
    Cornely, Oliver A.
    Watt, Maureen
    McCrea, Charles
    Goldenberg, Simon D.
    De Nigris, Enrico
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (09) : 2529 - 2539
  • [37] Fidaxomicin: A Macrocyclic Antibiotic for the Treatment of Clostridium difficile Infection
    Hardesty, Jennifer S.
    Juang, Paul
    PHARMACOTHERAPY, 2011, 31 (09): : 877 - 886
  • [38] Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea
    Sclar, David Alexander
    Robison, Linda M.
    Oganov, Ambartsum M.
    Schmidt, Jennifer M.
    Bowan, Kurt A.
    Castillo, Leigh V.
    CLINICAL DRUG INVESTIGATION, 2013, 33 (03) : 229 - 229
  • [39] Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea
    David Alexander Sclar
    Linda M. Robison
    Ambartsum M. Oganov
    Jennifer M. Schmidt
    Kurt A. Bowan
    Leigh V. Castillo
    Clinical Drug Investigation, 2013, 33 : 229 - 229
  • [40] Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection
    Zhanel, George G.
    Walkty, Andrew J.
    Karlowsky, James A.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2015, 26 (06): : 305 - 312